WHO pauses hydroxychloroquine studies over safety concerns
The World Health Organization announced Monday that it was pausing studies in multiple countries of hydroxychloroquine after an analysis of thousands of Covid-19 patients treated with the drug found that it was associated with a higher risk of death. The drug — an antimalarial that is also used routinely to treat rheumatoid arthritis — has…